Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Saved in:
| Title: | Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03. |
|---|---|
| Authors: | Garcia-Donas J; HM Hospitales-Centro Integral Oncológico HM Clara Campal, Oña Street 10, 28050, Madrid, Spain. jgarciadonas@hmhospitales.com., Hurtado A; Hospital Universitario Fundación Alcorcón, Alcorcón, Spain., Garrigos L; Hospital Universitario del Mar, Barcelona, Spain., Santaballa A; Hospital Universitario La Fe, Valencia, Spain., Redondo A; Hospital Universitario La Paz, Madrid, Spain., Vidal L; Hospital Universitario Clinico de Barcelona, Barcelona, Spain., Lainez N; Hospital de Navarra, Pamplona, Spain., Guerra E; Hospital Universitario Ramon y Cajal, Madrid, Spain., Rodriguez V; Hospital Universitario Valle Ebron, Barcelona, Spain., Cueva J; Complexo Hospital Universitario de Santiago de Compostela, Santiago de Compostela, Spain., Bover I; Hospital Universitario Son Llatzer, Mallorca, Spain., Palacio I; Hospital Central de Asturias, Oviedo, Spain., Rubio MJ; Hospital Universitario Reina Sofía, Cordoba, Spain., Prieto M; HM Hospitales-Centro Integral Oncológico HM Clara Campal, Oña Street 10, 28050, Madrid, Spain., Lopez-Guerrero JA; Fundacion Instituto Valenciano de Oncología, Valencia, Spain., Rodriguez-Moreno JF; HM Hospitales-Centro Integral Oncológico HM Clara Campal, Oña Street 10, 28050, Madrid, Spain., Garcia-Casado Z; Fundacion Instituto Valenciano de Oncología, Valencia, Spain., Garcia-Martinez E; Hospital General Universitario Morales Meseguer, Murcia, Spain., Taus A; Hospital Universitario del Mar, Barcelona, Spain., de Castro IP; Institute of Rare Diseases Research, Instituto de Salud Carlos III, Madrid, Spain., Navarro P; HM Hospitales-Centro Integral Oncológico HM Clara Campal, Oña Street 10, 28050, Madrid, Spain., Grande E; Anderson Cancer Center, Madrid, Spain. |
| Corporate Authors: | Spanish Group for Research in Orphan, Infrequent Tumors (GETHI) |
| Source: | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Jul; Vol. 25 (7), pp. 2090-2098. Date of Electronic Publication: 2023 Jan 28. |
| Publication Type: | Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36708371 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Garcia-Donas+J%22">Garcia-Donas J</searchLink>; HM Hospitales-Centro Integral Oncológico HM Clara Campal, Oña Street 10, 28050, Madrid, Spain. jgarciadonas@hmhospitales.com.<br /><searchLink fieldCode="AU" term="%22Hurtado+A%22">Hurtado A</searchLink>; Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.<br /><searchLink fieldCode="AU" term="%22Garrigos+L%22">Garrigos L</searchLink>; Hospital Universitario del Mar, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Santaballa+A%22">Santaballa A</searchLink>; Hospital Universitario La Fe, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Redondo+A%22">Redondo A</searchLink>; Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Vidal+L%22">Vidal L</searchLink>; Hospital Universitario Clinico de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lainez+N%22">Lainez N</searchLink>; Hospital de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Guerra+E%22">Guerra E</searchLink>; Hospital Universitario Ramon y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez+V%22">Rodriguez V</searchLink>; Hospital Universitario Valle Ebron, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cueva+J%22">Cueva J</searchLink>; Complexo Hospital Universitario de Santiago de Compostela, Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Bover+I%22">Bover I</searchLink>; Hospital Universitario Son Llatzer, Mallorca, Spain.<br /><searchLink fieldCode="AU" term="%22Palacio+I%22">Palacio I</searchLink>; Hospital Central de Asturias, Oviedo, Spain.<br /><searchLink fieldCode="AU" term="%22Rubio+MJ%22">Rubio MJ</searchLink>; Hospital Universitario Reina Sofía, Cordoba, Spain.<br /><searchLink fieldCode="AU" term="%22Prieto+M%22">Prieto M</searchLink>; HM Hospitales-Centro Integral Oncológico HM Clara Campal, Oña Street 10, 28050, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lopez-Guerrero+JA%22">Lopez-Guerrero JA</searchLink>; Fundacion Instituto Valenciano de Oncología, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Moreno+JF%22">Rodriguez-Moreno JF</searchLink>; HM Hospitales-Centro Integral Oncológico HM Clara Campal, Oña Street 10, 28050, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Casado+Z%22">Garcia-Casado Z</searchLink>; Fundacion Instituto Valenciano de Oncología, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Martinez+E%22">Garcia-Martinez E</searchLink>; Hospital General Universitario Morales Meseguer, Murcia, Spain.<br /><searchLink fieldCode="AU" term="%22Taus+A%22">Taus A</searchLink>; Hospital Universitario del Mar, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22de+Castro+IP%22">de Castro IP</searchLink>; Institute of Rare Diseases Research, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Navarro+P%22">Navarro P</searchLink>; HM Hospitales-Centro Integral Oncológico HM Clara Campal, Oña Street 10, 28050, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Grande+E%22">Grande E</searchLink>; Anderson Cancer Center, Madrid, Spain. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Spanish+Group+for+Research+in+Orphan%2C+Infrequent+Tumors+%28GETHI%29%22">Spanish Group for Research in Orphan, Infrequent Tumors (GETHI)</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101247119%22">Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</searchLink> [Clin Transl Oncol] 2023 Jul; Vol. 25 (7), pp. 2090-2098. <i>Date of Electronic Publication: </i>2023 Jan 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Italia%22">Springer Italia </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>101247119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1699-3055 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221699048X%22">1699048X </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36708371 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12094-023-03085-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2090 Titles: – TitleFull: Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Garcia-Donas J – PersonEntity: Name: NameFull: Hurtado A – PersonEntity: Name: NameFull: Garrigos L – PersonEntity: Name: NameFull: Santaballa A – PersonEntity: Name: NameFull: Redondo A – PersonEntity: Name: NameFull: Vidal L – PersonEntity: Name: NameFull: Lainez N – PersonEntity: Name: NameFull: Guerra E – PersonEntity: Name: NameFull: Rodriguez V – PersonEntity: Name: NameFull: Cueva J – PersonEntity: Name: NameFull: Bover I – PersonEntity: Name: NameFull: Palacio I – PersonEntity: Name: NameFull: Rubio MJ – PersonEntity: Name: NameFull: Prieto M – PersonEntity: Name: NameFull: Lopez-Guerrero JA – PersonEntity: Name: NameFull: Rodriguez-Moreno JF – PersonEntity: Name: NameFull: Garcia-Casado Z – PersonEntity: Name: NameFull: Garcia-Martinez E – PersonEntity: Name: NameFull: Taus A – PersonEntity: Name: NameFull: de Castro IP – PersonEntity: Name: NameFull: Navarro P – PersonEntity: Name: NameFull: Grande E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2023 Jul Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1699-3055 Numbering: – Type: volume Value: 25 – Type: issue Value: 7 Titles: – TitleFull: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico Type: main |
| ResultId | 1 |